BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37119181)

  • 1. Trends in Neonatal Opioid Withdrawal Syndrome and Opioid Exposure Diagnoses Among Infants With Private Health Insurance, 2016-2021: Introduction of the P04.14 ICD-10-CM Code.
    Campbell AG; Zhang P; Rosenman MB; Scott E; Wiehe SE
    Public Health Rep; 2024; 139(1):88-93. PubMed ID: 37119181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017.
    Goyal S; Saunders KC; Moore CS; Fillo KT; Ko JY; Manning SE; Shapiro-Mendoza C; Gupta M; Romero L; Coy KC; McDow KB; Keaton AA; Sinatra J; Jones K; Alpren C; Barfield WD; Diop H
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):951-955. PubMed ID: 32701936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
    Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.
    Shrestha S; Roberts MH; Maxwell JR; Leeman LM; Bakhireva LN
    Neurotoxicol Teratol; 2021; 86():106975. PubMed ID: 33766722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome.
    Maalouf FI; Cooper WO; Stratton SM; Dudley JA; Ko J; Banerji A; Patrick SW
    Pediatrics; 2019 Jan; 143(1):. PubMed ID: 30514781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
    Isaac L; van den Hoogen NJ; Habib S; Trang T
    J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
    Baldo BA
    Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging Existing Birth Defects Surveillance Infrastructure to Build Neonatal Abstinence Syndrome Surveillance Systems - Illinois, New Mexico, and Vermont, 2015-2016.
    Lind JN; Ailes EC; Alter CC; Fornoff JE; Brozicevic P; Garcia Saavedra LF; Tomedi LE; Gambatese M; Carroll B; Orantes L; Martin B; Horne AA; Reefhuis J
    MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(7):177-180. PubMed ID: 30789880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
    Hussaini KS; Garcia Saavedra LF
    Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Neonates With Laryngomalacia and Neonatal Abstinence Syndrome.
    Abraham EJ; Danis DO; Levi JR
    Ann Otol Rhinol Laryngol; 2022 Sep; 131(9):946-953. PubMed ID: 34595938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017.
    Ko JY; Hirai AH; Owens PL; Stocks C; Patrick SW
    Hosp Pediatr; 2021 Aug; 11(8):902-908. PubMed ID: 34321311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
    Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB
    Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
    Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR
    J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis.
    Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C
    Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.
    Patrick SW; Schumacher RE; Benneyworth BD; Krans EE; McAllister JM; Davis MM
    JAMA; 2012 May; 307(18):1934-40. PubMed ID: 22546608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Neonatal Abstinence Syndrome Surveillance - Pennsylvania, 2019.
    Krause KH; Gruber JF; Ailes EC; Anderson KN; Fields VL; Hauser K; Howells CL; Longenberger A; McClung N; Oakley LP; Reefhuis J; Honein MA; Watkins SM
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):40-45. PubMed ID: 33444296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
    Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
    Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Administrative Data for Identifying Maternal Opioid Use at Delivery in Florida.
    Elmore AL; Salemi JL; Kirby RS; Sappenfield WM; Lowry J; Dixon A; Lake-Burger H; Tanner JP
    Matern Child Health J; 2023 Dec; 27(Suppl 1):44-51. PubMed ID: 37199857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.